Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-9 ل  9 نتائج ل ""MESH: COVID-19 / drug therapy""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Subjects: COVID-19; Hydroxychloroquine; Interferon β-1a

  • Source: ISSN: 1198-743X.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure

Subjects: MESH: Aged; MESH: Albumins / metabolism; MESH: Lopinavir / therapeutic use

  • Source: ISSN: 0009-9236.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19

Subjects: COVID-19; Intensive care unit; Mortality

  • Source: ISSN: 2050-6511 ; BMC Pharmacology and Toxicology ; https://ut3-toulouseinp.hal.science/hal-03683634 ; BMC Pharmacology and Toxicology, 2021, 22, pp.14. ⟨10.1186/s40360-021-00480-3⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

When Therapeutic IgA Antibodies Might Come of Age

Subjects: Immunoglobulin A; Therapeutic antibody; Bioengineering

  • Source: ISSN: 0031-7012.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Subjects: 0301 basic medicine; [SDV]Life Sciences [q-bio]; Lopinavir/ritonavir

  • Source: Clinical Microbiology and InfectionClinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, S1198-743X (21), pp.00259-7.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

When Therapeutic IgA Antibodies Might Come of Age

Subjects: Immunoglobulin A; MESH: Immunoglobulin A / adverse effects; MESH: Neoplasms / immunology

  • Source: PharmacologyPharmacology, 2021, 106 (1-2), pp.9-19. ⟨10.1159/000510251⟩Pharmacology, Karger, 2021, 106 (1-2), pp.9-19. ⟨10.1159/000510251⟩

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

Outcome of patients hospitalized for Covid‐19 and exposure to angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers in France: Results of the ACECoV study

Subjects: Male; MESH: Hypertension / complications; pharmacoepidemiology

  • Source: Fundamental & Clinical PharmacologyFundamental and Clinical PharmacologyFundamental and Clinical Pharmacology, Wiley, 2021, Fundamental & Clinical Pharmacology, 35 (1), pp.194-203.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure

Subjects: Male; MESH: Antiviral Agents / therapeutic use; MESH: COVID-19 / drug therapy

  • Source: Clinical Pharmacology & TherapeuticsClinical Pharmacology and TherapeuticsClinical Pharmacology and Therapeutics, 2021, Therapeutic Innovations in Infectious Diseases, 109 (4),

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics

Subjects: 0301 basic medicine; Microbiology (medical); 2019-20 coronavirus outbreak

  • Source: Clinical Infectious DiseasesClinical Infectious Diseases, Oxford University Press (OUP), 2020, ⟨10.1093/cid/ciaa558⟩Clinical Infectious Diseases: An Official Publication of the

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-9 ل  9 نتائج ل ""MESH: COVID-19 / drug therapy""